Mycoplasma arthritidis mitogen up-regulates human NK cell activity

Infection and Immunity

Volumn 64, Issue 2, 1996, Pages 441-447

  D'Orazio, John A ^a   Cole, Barry C ^a   Stein Streilein, Joan ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGENIC AGENT; SUPERANTIGEN;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; MYCOPLASMA ARTHRITIDIS; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0030053426     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.2.441-447.1996     Document Type: Article

References (65)

1. Acharya, K. R., E. F. Passalaoqua, E. Y. Jones, K. Harlos, D. I. Stuart, R. D. Brehm, and H. S. Trauter. 1994. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature (London) 367:94-97.
2. Atkin, C. L., B. C. Cole, G. J. Sullivan, L. R. Washburn, and B. B. Wiley. 1986. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V A small basic protein from culture supernatants is a potent T cell mitogen. J. Immunol 137:1581-1589.
3. Atkin, C. L., S. Wei, and B. C. Cole. 1994 The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide. Infect Immun. 62:5367-5375
4. Belfrage, H., P. Bhiladvala, G. Hedlund, M. Dohlsten, and T. Kalland. 1994. Combined activation of murine lymphocytes with staphylocoecal enterotoxin and interleukin-2 results in additive cytotoxic activity. Cancer Immunol. Immunother 38:265-271.
5. Bianco, C., R. Patrick, and V. Nussenzweig. 1970. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization J. Exp Med. 132:702-720
6. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human peripheral blood Scand J. Clin. Lab. Invest. Suppl 21:77-89
7. Brooks, C. F., and M. Moore. 1986 Presentation of a soluble bacterial antigen and cell-surface alloantigens by large granular lymphocytes (LGL) in comparison with monocytes. Immunology 58:343-350.
8. Callewaert, D. M., S. P. Smeekens, and N. H. Mahle. 1982 Improved quantification of cellular cytotoxicity reactions: determination of kinetic parameters for natural cytotoxicity by a distribution-free procedure J. Immunol Methods 49:25-37.
9. Cannon, G. W., B. C. Cole, and J. R. Ward. 1986. Differential effects of in vitro gold sodium thiomalate on the stimulation of human peripheral blood mononuclear cells by mycoplasma arthritidis T cell mitogen, concanavalin A and phytohaemagglutinin J. Rheumatol. 13:52-57
10. Chang, H.-L., M. H. Zaroukian, M. H. Morrison, and W. J. Esselman. 1989. Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity. Nat. Immun. Cell Growth Regul. 8:89-99.
11. Chatila, T., and R. F. Geha. 1993 Signal transduction by microbial superantigens via MHC class II molecules. Immunol, Rev. 131:43-59.
12. Cole, B. C., and C. L. Atkin. 1991. The Mycoplasma arthritidis T-cell mitogen MAM. a model superantigen. Immunol. Today 12:271-276.
13. Cole, B. C., C. S. David, D. H. Lynch, and D. R. Kartchner. 1990. The use of transfected fibroblasts and transgenic mice establishes that stimulation of T cells by the Mycoplasma arthritidis mitogen is mediated by Eα. J Immunol. 144:420-424.
14. Cole, B. C., R. A. Daynes, and J. R. Ward. 1981 Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. I. Transformation K associated with an H-2-linked gene that maps to the I-E/I-C subregion. J. Immunol. 127:1931-1936
15. Cole, B. C., R. A. Daynes, and J. R. Ward. 1982. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. III. Ir gene control of lymphocyte transformation correlates with binding of the mitogen to specific Ia-bearing cells. J. Immunol 129:1352-1359.
16. β8 gene family present on the T cell receptor α/β for antigen. J Immunol. 142:4131-4137
17. Cole, B. C., D. R. Kartchner, and D. J. Wells. 1990. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM. J. Immunol. 144:425-431.
18. Cole, B. C., G. J. Sullivan, R. A. Daynes, I. A. Sayed, and J. R. Ward. 1982. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. II Cellular requirements for T cell transformation mediated by a soluble mycoplasma mitogen J. Immunol. 128:2013-2018.
19. Cole, B. C., J. W. Tuller, and G. J. Sullivan. 1987 Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VI. Detection of a non-MHC gene(s) in the Eα-bearing RIIIS mouse stiam that is associated with a specific lack of T cell responses to the M. arthritidis soluble mitogen. J. Immunol. 139:927-935.
20. Dannemann, B. R., V. A. Morris, F. G. Araujo, and J. S. Remington. 1989 Assessment of human natural killer and lymphokine-activated killer cell cytoxicity against Toxoplasma gondit trophozoites and brain cysts J Immunol. 143:2684.
21. DeLerma, B. A., S. Sartoris, G. Tosi, M. Nicolis, and R. S. Accolla. 1994 Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules. J. Immunol 153: 4530-4538.
22. Dellabona, P., J. Peccoud, J. Kappler, P. Marrack, C. Benoist, and D. Mathis. 1990. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121.
23. Dohlsten, M., L. Abrahmsen, P. Bjork, P. A. Lando, G. Hedlund, G. Forsberg, T. Brodin, N. R. J. Gascoigne, C. Forherg, P. Lind, and J. Kalland. 1994. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy Proc. Natl. Acad Sci USA 91:8945-8949.
24. D'Orazio, J. A., G. W. Burke III. and J. Stein-Streilein. 1995 Staphylococcal enterotoxin B (SEB) causes purified NK cells to secrete interferon gamma, but requires T lymphocytes to augment NK cytotoxicity. J. Immunol 154: 1014-1023
25. 24a. D'Orazio, J. A., and J. Stein-Streilein. Submitted for publication
26. Drake, C. G., and B. L. Kotzin. 1992. Superantigens: biology, immunology, and potential role in disease J. Clin Immunol. 12:149-162.
27. Edelson, P. J., and Z. A. Cohn. 1976. Purification and cultivation of monocytes and macrophages, p. 333-340. In B A Bloom and J. R. David (ed.), In vitro methods in cell-mediated and tumor immunity. Academic Press Inc., San Diego, Calif.
28. Epstein, M. A., B. G. Achong, Y. M. Barr, B. Zajac, G. Henle, and W. Henle. 1966. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji) J. Nat Cancer Inst. 37:547-559
29. Figlin, R. A., W. C. Pierce, and A. Belldegrun. 1993 Combination biologic therapy with interleukin-2 and interferon-alpha in the outpatient treatment of metastatic renal cell carcinoma. Semin. Oncol. 20(6 Suppl. 9):11-15.
30. Fleischer, B. 1991 The human T cell response to mitogenic microbial exotoxins. Curr. Top. Microbiol Immunol. 174:53-62.
31. Fleischer, B., R. Gerardy-Schahn, B. Mezroth, S. Carrel, D. Gerlach, and W. Köhler. 1991. An evolutionary conserved mechanism of T cell activation by microbial toxins: evidence for different affinities of T cell receptor-toxin interaction. J. Immunol. 146:11-17.
32. Fuleihan, R., W. Mourad, R. S. Geha, and T. Chatila. 1991. Engagement of MHC-class II molecules by Staphylococcal enterotoxins delivers a comitogenic signal to human B cells. J. Immunol 146:1661-1666.
33. Garcia-Peñarrubia, P., F. T. Koster, R. O. Kelley, T. D. McDowell, and A. D. Bankhurst. 1989. Antibacterial activity of human natural killer cells. J Exp. Med 169:99-113
34. Gismondi, A., F. Mainiero, S. Morrone, G. Palmieri, M. Piccoli, L. Frati, and A. Santoni. 1992. Triggering through CD16 or phorbol esters enhances adhesion of NK cells to laminin via very late antigen 6. J. Exp. Med. 176: 1251-1257.
35. Hawkins, M. J. 1993. Interleukin-2 antitumor and effector cell responses. Semin Oncol 20(b Suppl. 9):52-59
36. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
37. Ihle, J., U. Holzer, F. Krull, M. Dohlsten, T. Kalland, D. Niethammer, and G. E. Dannecker. 1995. Elevated NK sensitivity of Raji cells carrying acccptor-bound C3 fragments. Cell Immunol. 113:227-234.
38. Kirchner, H., D. Giebler, K. Keyssner, and W. Nicklas. 1984. Lymphoproliferation induced in mouse spleen cells by Mycoplasma arthritidis mitogen. Scand. J. Immunol. 20:133-139
39. Klein, E., H. Ben-Bassat, H. Neumann, P. Ralph, J. Zeuther, A. Polliack, and F. Vanky. 1976 Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia Int. J. Cancer 18:421.
40. H1 helper/killer T cells and application to tumor immunotherapy. J. Immunol. 154:1777-1785.
41. Labrecque, N., J. Thibodeau, and R.-P. Sékaly. 1993. Interactions between staphylococcal superantigens and MHC class II molecules Semin. Immunol. 5:23-32
42. Lai, W. C., M. Bennett, S. P. Pakes, V. Kumar, D. Steutermann, I. Owusu, and A. Mikhael. 1990. Resistance to Mycoplasma pulmonis mediated by activated natural killer cells J. Infect. Dis. 161:1269-1275.
43. Matthes, M., H. Schrezenmeier, J. Homfeld, S. Fleischer, B. Malissen, H. Kirchner, and B. Fleischer. 1988 Clonal analysis of human T cell activation by the Mycoplasma arthritidis mitogen (MAM). Eur J Immunol. 18:1733-1737.
44. Melder, R. J., E. Walker, R. B. Herberman, and T. L. Whiteside. 1991. Adhesion characteristics of human interleukin 2-activated natural killer cells. Cell Immunol 132:177-192
45. Ng, A.-K., F. Indiveri, M. A. Pellegrino, G. A. Molinaro, V. Quaranta, and S. Ferrone. 1980 Natural cytotoxicity and antibody-dependent cellular cytotoxicity of human lymphocytes depleted of HLA-DR bearing cells with monoclonal HLA-DR antibodies. J. Immunol. 124:2336-2340.
46. Parsonnet, J., and Z. A. Gillis. 1988. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1 J. Infect. Dis. 158:1026-1033
47. Parsonnet, J., R. K. Hickman, D. P. Eardley, and G. B. Pier. 1985. Induction of human interleukin-l by toxic shock syndrome toxin-1. J. Infect. Dis 151:514.
48. Pirelli, A., P. Allavena, and A. Mantovani. 1988. Activated adherent large granular lymphocytes/natural killer (LGL/NK) cells change their migratory behavior. Immunology 65:651-655
49. Pockaj, B. A., S. L. Topalian, S. M. Steinberg, D. E. White, and S. A. Rosenberg. 1993 Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses. J. Clin Oncol 11:136-147
50. Pross, H. F., M. G. Baines, P. Rubin, P. Shragge, and M. S. Patterson. 1981. Spontaneous human lymphocyte-mediated cytotoxicity against tumor targets IX. The quantification of natural killer activity J. Clin. Immunol 1:51-63.
51. Pross, H. F., and E. Lotzová. 1993. Role of natural killer cells in cancer Nat. Immunity 12:279-292.
52. Rink, L., A. Kruse, W. Nicklas, J. Hoyer, and H. Kirchner. 1992. Induction of cytokines in human peripheral blood and spleen cells by the Mycoplasma arthritidis-derived superantigen. Lymphokine Cytokine Res. 11:105-108.
53. H2 responses, a key role for the "natural' immune response? Immunol Today 13:379-381.
54. Roncarolo, M.-G., M. Bigler, J. B. A. Haanen, H. Yssel, R. Bachetta, J. E. deVries, and H. Spits. 1991 Natural killer cell clones can efficiently process and present protein antigens J Immunol. 147:781-787
55. Rosenberg, S. A. 1991. Immunotherapy and gene therapy of cancer. Cancer Res. 51(18 Suppl.):5074s-507s.
56. Shu, S., R. A. Krinock, T. Màtsumura, J. J. Sussman, B. A. Fox, A. E. Chang, and D. S. Terman. 1994. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumorspecific effector T cells. J. Immunol. 152:1277-1288.
57. Spertini, F., H. Spits, and R. S. Geha. 1991. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules Proc. Natl. Acad. Sci. USA 88:7533-7537.
58. Subauste, C. S., L. Dawson, and J. S. Remington. 1992. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii. J. Exp. Med 176:1511-1519.
59. Swaminathan, S., W. Furey, J. Pletcher, and M. Sax. 1992. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature (London) 359:801-806.
60. Trede, N. S., E. Castigli, R. S. Geha, and T. Chatila. 1993 Microbial super antigens induce NK-κB in the human monocytic cell line THP-1. J. Immunol. 150:5604-5613.
61. Trede, N. S., R. S. Geha, and T. Chatila. 1991. Transcriptional activation of IL-1β and tumor necrosis factor-α genes by MHC class II ligands. J. Immunol 146:2310-2315
62. Trede, N. S., T. Morio, P. R. Scholl, R. S. Geha, and T. Chatila. 1994. Early activation events induced by the staphylococcal superantigen toxic shock syndrome toxin-1 in human peripheral blood monocytes Clin. Immunol. Immunopathol 70:137-144.
63. Tumang, J. R., E. P. Cherniak, D. M. Gietl, B. C. Cole, C. Russo, M. K. Crow, and S. M. Friedman. 1991. T helper cell-dependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses. J. Immunol 147:432-438.
64. Weber, J. S., J. C. Yang, S. L. Topalian, D. J. Sehwartzentruber, D. E. White, and S. A. Rosenberg. 1992. The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma. J. Clin Oncol. 10:33-40.
65. Whittington, R., and D. Faulds. 1993 Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 46:446-514